Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility.

Pharmacogenetics - 1 Dec 1993

Buchert E T, Woosley R L, Swain S M, Oliver S J, Coughlin S S, Pickle L, Trock B, Riegel A T

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Base Sequence
Share to Breast Neoplasms
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to DNA Primers

Share to Gene Frequency

Share to Mixed Function Oxygenases

Source

Identifiers

PMID: 8148873
DOI: 10.1097/00008571-199312000-00006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility.PMID 8148873Read ↗

CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapySemantic proximity Read ↗

Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility.Semantic proximity Read ↗

Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast CancerSemantic proximity Read ↗

CYP2D6 and tamoxifen: DNA matters in breast cancer.Semantic proximity Read ↗

CYP2D6 gene variants and their association with breast cancer susceptibility.Semantic proximity Read ↗

Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen.Semantic proximity Read ↗

CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.Semantic proximity Read ↗

Debrisoquine 4-hydroxylation (CYP2D6) polymorphism in Jordanians.Semantic proximity Read ↗

Identification of the primary gene defect at the cytochrome P450 CYP2D locus.Semantic proximity Read ↗

CYP2D6 Polymorphisms and Tamoxifen Metabolism: Clinical RelevanceSemantic proximity Read ↗

CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.Semantic proximity Read ↗

Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.